Teva Pharmaceutical Industries "buy," target price reduced

11/04/09 - Jefferies & Co

NEW YORK, November 4 (newratings.com) - Analysts at Jefferies & Co reiterate their "buy" rating on Teva Pharmaceutical Industries Limited (TEVA). The target price has been reduced from $63 to $61.